NEW YORK (GenomeWeb) – The National Institute of Mental Health plans to fund new research that will explore molecular and cellular alterations that are associated with complex brain disorders, and how they impact neuronal function.

NIMH said yesterday in a funding announcement it wants to spur more knowledge about how these alterations are involved in "some of the biggest challenges facing neuroscience" — disorders such as schizophrenia, depression, bipolar and anxiety disorders, and autism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.